NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -25.04% | 4.59% | 4.13% | 9.17% | 15.97% |
| Total Other Revenue | -- | 0.00% | -- | -66.67% | -94.12% |
| Total Revenue | -25.04% | 4.59% | 4.13% | 9.15% | 15.84% |
| Cost of Revenue | -6.60% | -8.15% | 6.56% | 8.04% | 1.77% |
| Gross Profit | -34.61% | 12.07% | 2.76% | 9.76% | 24.78% |
| SG&A Expenses | -47.42% | -9.90% | 11.52% | 14.48% | 27.84% |
| Depreciation & Amortization | -51.21% | -51.23% | -51.21% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.25% | -7.89% | 1.46% | 9.22% | 21.08% |
| Operating Income | 64.64% | 25.48% | 2.06% | -9.32% | -27.88% |
| Income Before Tax | -9.26% | -40.17% | 23.62% | -56.11% | -25.56% |
| Income Tax Expenses | 640.00% | -224.14% | 270.00% | -492.11% | -143.48% |
| Earnings from Continuing Operations | -9.74% | -39.75% | 23.25% | -53.62% | -25.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.74% | -39.75% | 23.25% | -53.61% | -25.95% |
| EBIT | 64.64% | 25.48% | 2.06% | -9.32% | -27.88% |
| EBITDA | 98.62% | 28.39% | 1.54% | -11.18% | -32.25% |
| EPS Basic | 43.68% | -39.75% | 23.27% | -53.49% | -25.62% |
| Normalized Basic EPS | 64.60% | -40.18% | 21.13% | -54.74% | -26.44% |
| EPS Diluted | 43.68% | -39.75% | 23.23% | -56.66% | -25.62% |
| Normalized Diluted EPS | 64.60% | -40.18% | 21.13% | -54.74% | -26.44% |
| Average Basic Shares Outstanding | 94.84% | 0.00% | 0.02% | 0.08% | 0.27% |
| Average Diluted Shares Outstanding | 94.84% | 0.00% | 0.02% | 0.08% | 0.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |